• Follow
  • Follow
  • Menu Item

Log in

Start free trial
  • Reports
    • Diagnostic Testing & Emerging Technologies
    • Lab Compliance Advisor
    • Laboratory Industry Report
    • National Lab Reporter
  • Articles
    • Diagnostic Testing and Emerging Technologies
      • DTC-dtet
      • Earnings-dtet
      • Emerging Tests-dtet
      • FDA-dtet
      • G2 Insider-dtet
    • Lab Compliance Advisor
      • Accreditation-lca
      • Brief Your CEO-lca
      • CLIA-lca
      • CMS-lca
      • Coding-lca
      • Compliance Corner-lca
      • Compliance Guidance-lca
      • Compliance Officers-lca
      • Compliance Perspectives-lca
      • Compliance Plans-lca
      • Compliance-lca
      • DOJ-lca
      • Employment-lca
      • Enforcement-lca
      • False Claims-lca
      • FDA-lca
    • Laboratory Industry Report
      • Capital-lir
      • CMS-lir
      • Deals-lir
      • Dx Pipeline-lir
      • Earnings-lir
      • Enforcement-lir
      • FDA-lir
      • Fee Schedules-lir
      • Funding-lir
    • National Lab Reporter
      • Guidelines at a Glance-nir
      • Health care reform-nir
      • HIPAA-nir
      • Labs in Court-nir
      • Legislation-nir
      • News-nir
      • OIG-nir
      • Reimbursement-nir
      • Safety-nir
  • News
  • Industry Perspectives
  • Webinars
  • Store

Diagnostic Testing and Emerging Technologies

LAB COMPLIANCE ADVISOR

LABORATORY INDUSTRY REPORT

NATIONAL LAB REPORTER

New Test May Make It Faster, Cheaper, and Easier to Detect Aneuploidy

New Test May Make It Faster, Cheaper, and Easier to Detect Aneuploidy

by Rachel Muenz | Aug 23, 2022 | News

New Short-read Transpore Rapid Karyotyping test can identify fetal chromosomal abnormalities in a variety of samples.

Thermo Fisher Teams with Rosalind & Helix for Rapid SARS-CoV-2 Variant Detection

Thermo Fisher Teams with Rosalind & Helix for Rapid SARS-CoV-2 Variant Detection

by Glenn S. Demby | Mar 29, 2022 | Articles, News, Open Content

Thermo Fisher Scientific announced that it has teamed with Helix and Rosalind, Inc. on a National Institutes of Health (NIH)-supported project to develop a new SARS-CoV-2 genotyping method allowing for more rapid and cost-effective identification of virus variants...
NCI Program Expands Access to Key Diagnostic for Childhood Cancers

NCI Program Expands Access to Key Diagnostic for Childhood Cancers

by Rachel Muenz | Mar 28, 2022 | Articles, News, Open Content

A new initiative launched by the National Institutes of Health’s National Cancer Institute (NCI) on March 21 will bring a state-of-the art diagnostic option to children, adolescents, and young adults who have recently been diagnosed with central nervous system tumors....
Partnership to Accelerate SARS-CoV-2 Variant Identification in the US

Partnership to Accelerate SARS-CoV-2 Variant Identification in the US

by Rachel Muenz | Mar 23, 2022 | Articles, News, Open Content

On March 23, Thermo Fisher Scientific announced it is partnering with population genomics company Helix, bioinformatics company Rosalind, and the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) Initiative to identify SARS-CoV-2 variants...
NIH Sees Budget Increase by $2 Billion

NIH Sees Budget Increase by $2 Billion

by Rachel Muenz | Mar 18, 2022 | Articles, News, Open Content

On March 15, President Biden signed the Consolidated Appropriations Act, 2022 into law, an omnibus bill that sets the budgets for all federal agencies for the rest of FY2022. The bill includes a $2 billion increase for the National Institutes of Health (NIH), bringing...
« Older Entries

Log In


Join Now | Lost Password?

  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
Copyright © 2023 G2Intelligence.com